Case Name: Bausch Health Ireland Ltd. v. Mylan Labs. Ltd., No. 21-10403 (SRC) (JSA), 2022 WL 683084 (D.N.J. Mar. 8, 2022) (Chesler, J.) Drug Product and Patent(s)-in ...
NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...
Billionaire investor Carl Icahn has dropped his $5.39 billion offer to buy Mylan Laboratories Inc. and tendered his shares after regulators opened an investigation of a Mylan pain patch that was ...
SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. shares were down 12% at $20.20 in late afternoon trade Monday in what the company called an "overreaction" to the Food and Drug Administration's ...
SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. said Wednesday it will reorganize following its acquisition of a controlling interest in Matrix Laboratories. The company said Chief Scientific ...
PITTSBURGH (AP) -- One of the world's largest generic drug makers, Mylan Laboratories Inc., will buy King Pharmaceuticals Inc. for $4 billion in stock as Mylan makes a stronger foray into the branded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results